Sanofi pumps up animal health in India with Dosch deal; Mylan pulls painkillers on potency worries;

@FiercePharma: Judge thwarts Endo's effort to block non-tamper-resistant copies of Opana ER. FDA still might, tho. More | Follow @FiercePharma

> Sanofi ($SNY) plans to beef up its animal health business Merial with the acquisition of India-based Dosch Pharmaceuticals' veterinary business. Report

> Allergan ($AGN) wrapped up its $350 million buyout of dermatology drugmaker Skin Medica. Report

> Mylan ($MYL) pulled three lots of painkillers, including the opioid Vicodin, because of worries that tablets were too large and too potent; the drugs were made by contract manufacturer Qualitest. Report

> Lundbeck's stock may have taken a plunge, but that probably doesn't make it a takeover target, because it's 70% owned by a family foundation. Report

> Orion settled a lawsuit with Mylan, granting the generics maker the right to sell a copy of its Parkinson's drug Comtan in April 2013 at the earliest. Report

> The FDA met with state health officials to discuss heightened oversight of compounding pharmacies, which have been in the spotlight since a deadly meningitis outbreak began. Report (sub. req.)

> Morningstar analysts tapped several pharma stocks as favorites for their dividend yields, including GlaxoSmithKline ($GSK), Eli Lilly ($LLY) and Novartis ($NVS). Report

Medical Device News

 @FierceMedDev: DioGenix Series B funds crucial trial for MS Dx. Story | Follow @FierceMedDev

@MarkHFierce: A Novartis subsidiary is licensing Trovagene's find that a certain protein, found in urine, can indicate leukemia. News | Follow @MarkHFierce

 @DamianFierce: Privately held CardiacAssist is targeting the heart pump market after getting FDA OK for a pivotal trial. More | Follow @DamianFierce

> Covidien's catheter posts sterling 5-year results. Report

> Analyst report: Med Tech M&A and restructuring to surge in 2013. Article

Biotech News

 @FierceBiotech: Nuron Biotech bags $80M deal to back vaccines portfolio, PhIII multiplesclerosis drug work. Story | Follow @FierceBiotech

@JohnCFierce: Tredaptive failure likely to leave a mark at Merck, which spends more than $8B a year on R&D. This could trigger a reorg. News | Follow @JohnCFierce

@RyanMFierce: Biogen is teaming up on ALS research w/ experts @ Yale Harvard & Columbia, committing $10M+, as its ALS rx is in P3. Release | Follow @RyanMFierce

> Roche's sweet spot: The $6B-$7B acquisition deal. Item

> Investors gamble $75M on Ultragenyx's plan to jump-start rare-disease player. Report

Pharma Manufacturing News

> Hot for fish oil, BASF expands plant, pursues Pronova. News

> India API makers complain about cheap Chinese imports. Story

Vaccines News

 @AlisonBFierce: India is cruising along in the vaccines market. A WHO clearance will hoist the country's vaccine exports. More | Follow @AlisonBFierce

> WHO clearance to hoist Indian vaccine exports. Report

> GSK teams with GlycoVaxyn to develop anti-bacterial vaccines. Article

> U.N. contemplates ban on vaccine preservative. News

> FDA approves GSK's quadrivalent flu vaccine. Story

> Georgia State scientists investigate universal flu vaccine. More

And Finally ... Bouts of deep concentration à la Sherlock Holmes, even in small doses, may make us better multitaskers. Report (sub. req.)